TABLE 2.
Participant characteristics1
| CD (n = 14) | TRF (n = 13) | TRFHMB (n = 13) | P (group) | |
|---|---|---|---|---|
| Age, y | 22.0 ± 2.4 | 22.1 ± 2.1 | 22.3 ± 3.4 | 0.95 |
| Body mass, kg | 64.6 ± 8.8 | 63.8 ± 8.5 | 63.2 ± 6.1 | 0.89 |
| Height, cm | 169.4 ± 7.5 | 163.6 ± 5.9 | 166.0 ± 4.8 | 0.07 |
| RT experience, y | 5.4 ± 3.0 | 5.0 ± 1.9 | 5.1 ± 2.1 | 0.85 |
| Current RT, d/wk | 2.9 ± 0.5 | 3.3 ± 0.6 | 3.0 ± 0.9 | 0.22 |
1Data are presented as mean ± SE. P values are from one-factor ANOVA. Data from intention-to-treat analysis are displayed, and data from per protocol analysis are displayed in the online supporting material. CD, control diet; RT, resistance training; TRF, time-restricted feeding; TRFHMB, time-restricted feeding plus β-hydroxy β-methylbutyrate supplementation.